Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

1

JARMS. 2013; 5(2): 135-138


Serum 5´Adenosine deaminase, 5´Nucleotidase in breast carcinoma in stagewise manner.

*Smita G.Narad,**S.M.Vaidya.

Abstract
Every year breast cancer afflicting females claims the lives of thousands of women all over the globe. The aim of the study was to assign relative significance of 5´Adenosine deaminase [5´ADA] and 5´ Nucleotidase [5´NT] as a marker for diagnosis of Carcinoma Breast and to evaluate correlation between levels of these enzymes and stages of malignancy, presence of metastasis and response to treatment. 50 diagnosed patients of carcinoma of breast before any treatment were grouped as untreated group and compared with normal controls (50). Untreated patients followed up after 3 months of treatment were estimated for above enzymes. These serum levels were compared with that of untreated patients. Serum 5´ADA & 5´NT levels were increased significantly in cases as compared to controls. There was progressive increase in the concentration of enzymes from Stage I to Stage IV in untreated patients. The decrease in serum 5´ADA level was also parallel to the stage in treated group. Reduction in level of 5´NT was significant in Stage I and II while nonsignificant in Stage III & Stage IV. When mean reduction of enzyme levels after treatment was compared in patients with secondaries & without secondaries it was more appreciable for 5´ADA than 5´NT. Thus from our study 5´ ADA may serve as diagnostic tumour marker and has important role in predicting progression and regression of disease in course of treatment. Serum5´Nucleotidase has the only diagnostic significance and raised value may predict the extent if disease.

Key words: Carcinoma breast, Serum 5´Adenosine deaminase, 5´Nucleotidase.



Share this Article


Advertisement
Progress in Orthopedic Science

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons